Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program. Chen C-H, Kularatna G, Stone CD, Gutierrez AM, Dassopoulos T Ann Gastroenterol. 2013; 26(3):189-190. PMID: 24714228. Abstract CommentRecommendBookmarkWatch